Alzheimer’s Disease is a progressive terminal disease. Many treatments are focused on lifestyle modification to delay diagnosis and onset. Join host, Geoff Wall, with guest Jake Galdo, as they look at a new study evaluating the association between vaccines and the development of Alzheimer’s Disease.

THE GAMECHANGER: Postviral inflammation may play a role in the development of Alzheimer’s Disease. A recent claims-based study found an association between immunization status and the development of Alzheimer’s Disease.

Upon successful completion of this course, learners should be able to:
1. Discuss the potential mechanisms of inflammation and viral infections with the development of Alzheimer’s Disease.
2. Describe the study discussed and its application in guiding patients to receive vaccines.

Geoffrey C. Wall, PharmD, FCCP, BCPS, CG
Professor of Clinical Sciences
Drake University College of Pharmacy and Health Sciences

Jake Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Managing Network Facilitator, CPESN Health Equity
CEO, Seguridad

Dr. Wall is a member of the Janssen Speaker’s Bureau. All relevant financial relationships have been mitigated.  

Dr. Galdo has no relevant financial relationships with ineligible companies to disclose. 

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Release Date: December 11, 2023
Planned Expiration Date: December 11, 2024

Copyright 2023, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.